Search Results

There are 4221 results for: content related to: Therapy management of cardiovascular adverse events in the context of targeted therapy for metastatic renal cell carcinoma

  1. You have full text access to this OnlineOpen article
    Overall survival and final efficacy and safety results from a Japanese phase II study of axitinib in cytokine-refractory metastatic renal cell carcinoma

    Cancer Science

    Volume 105, Issue 12, December 2014, Pages: 1576–1583, Masatoshi Eto, Hirotsugu Uemura, Yoshihiko Tomita, Hiroomi Kanayama, Nobuo Shinohara, Yoichi Kamei, Yosuke Fujii, Yoshiko Umeyama, Seiichiro Ozono, Seiji Naito, Hideyuki Akaza and the Japan Axitinib Phase II Study Group

    Version of Record online : 25 NOV 2014, DOI: 10.1111/cas.12546

  2. You have free access to this content
    Abstracts

    BJU International

    Volume 116, Issue S5, December 2015, Pages: 1–23,

    Version of Record online : 9 DEC 2015, DOI: 10.1111/bju.13365

  3. You have free access to this content
    Abstracts

    BJU International

    Volume 114, Issue S4, October 2014, Pages: 1–18,

    Version of Record online : 21 OCT 2014, DOI: 10.1111/bju.12941

  4. You have free access to this content
    Current management and future perspectives of metastatic renal cell carcinoma

    International Journal of Urology

    Volume 21, Issue 9, September 2014, Pages: 847–855, Richard Lee-Ying, Renee Lester and Daniel YC Heng

    Version of Record online : 27 MAY 2014, DOI: 10.1111/iju.12502

  5. You have free access to this content
    Axitinib in Metastatic Renal Cell Carcinoma: Results of a Pharmacokinetic and Pharmacodynamic Analysis

    The Journal of Clinical Pharmacology

    Volume 53, Issue 5, May 2013, Pages: 491–504, Brian I. Rini, May Garrett, Bill Poland, Janice P. Dutcher, Olivier Rixe, George Wilding, Walter M. Stadler, Yazdi K. Pithavala, Sinil Kim, Jamal Tarazi and Robert J. Motzer

    Version of Record online : 28 MAR 2013, DOI: 10.1002/jcph.73

  6. Immunotherapy for metastatic renal cell carcinoma

    Intervention Review

    The Cochrane Library

    Susanne Unverzagt, Ines Moldenhauer, Monika Nothacker, Dorothea Roßmeißl, Andreas V Hadjinicolaou, Frank Peinemann, Francesco Greco and Barbara Seliger

    Published Online : 15 MAY 2017, DOI: 10.1002/14651858.CD011673.pub2

  7. You have free access to this content
    Population pharmacokinetic analysis of axitinib in healthy volunteers

    British Journal of Clinical Pharmacology

    Volume 77, Issue 3, March 2014, Pages: 480–492, May Garrett, Bill Poland, Meghan Brennan, Brian Hee, Yazdi K. Pithavala and Michael A. Amantea

    Version of Record online : 21 FEB 2014, DOI: 10.1111/bcp.12206

  8. You have free access to this content
    Abstracts

    BJU International

    Volume 118, Issue S5, December 2016, Pages: 4–30,

    Version of Record online : 17 NOV 2016, DOI: 10.1111/bju.13694

  9. You have free access to this content
    Recent advances in the treatment of advanced renal cell carcinoma: towards multidisciplinary personalized care

    BJU International

    Volume 110, Issue 9, November 2012, Pages: 1289–1300, Axel Bex, Martin Gore, Peter Mulders and Cora N. Sternberg

    Version of Record online : 30 MAR 2012, DOI: 10.1111/j.1464-410X.2012.11100.x

  10. You have full text access to this OnlineOpen article
    A Pharmacometric Framework for Axitinib Exposure, Efficacy, and Safety in Metastatic Renal Cell Carcinoma Patients

    CPT: Pharmacometrics & Systems Pharmacology

    Volume 6, Issue 6, June 2017, Pages: 373–382, E Schindler, MA Amantea, MO Karlsson and LE Friberg

    Version of Record online : 26 MAY 2017, DOI: 10.1002/psp4.12193

  11. You have free access to this content
    Recent advances in the treatment of metastatic renal cell carcinoma

    International Journal of Urology

    Volume 20, Issue 10, October 2013, Pages: 944–955, Hideyuki Abe and Takao Kamai

    Version of Record online : 21 MAY 2013, DOI: 10.1111/iju.12187

  12. You have free access to this content
    Treatment of renal cell carcinoma: Current status and future directions

    CA: A Cancer Journal for Clinicians

    Pedro C. Barata and Brian I. Rini

    Version of Record online : 29 SEP 2017, DOI: 10.3322/caac.21411

  13. You have free access to this content
    Abstracts

    BJU International

    Volume 112, Issue S3, November 2013, Pages: 1–17,

    Version of Record online : 23 OCT 2013, DOI: 10.1111/bju.12478

  14. You have free access to this content
    Activity of axitinib in patients with metastatic renal cell carcinoma previously treated with both vascular endothelial growth factor receptor tyrosine-kinase inhibitor and mammalian target of rapamycin inhibitor

    International Journal of Urology

    Volume 21, Issue 7, July 2014, Page: 740, Ryuichi Mizuno, Akira Miyajima and Mototsugu Oya

    Version of Record online : 27 MAR 2014, DOI: 10.1111/iju.12414

  15. Diagnosis of the performance of the state-specific multireference coupled-cluster method with different truncation schemes

    Journal of Computational Chemistry

    Volume 33, Issue 14, 30 May 2012, Pages: 1285–1303, Uttam Sinha Mahapatra and Sudip Chattopadhyay

    Version of Record online : 15 MAR 2012, DOI: 10.1002/jcc.22960

  16. You have free access to this content
    Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti-angiogenic treatment

    BJU International

    Volume 109, Issue 2, January 2012, Pages: 200–206, Andrea Mancuso, Eugenio Donato Di Paola, Alvaro Leone, Alfonso Catalano, Fabio Calabrò, Linda Cerbone, Andrea Zivi, Carlo Messina, Silvia Alonso, Leonardo Vigna, Rita Caristo and Cora N. Sternberg

    Version of Record online : 23 DEC 2011, DOI: 10.1111/j.1464-410X.2011.10421.x

  17. You have full text access to this OnlineOpen article
    Prognosis of metastatic renal cell carcinoma with first-line interferon-α therapy in the era of molecular-targeted therapy

    Cancer Science

    Volume 107, Issue 7, July 2016, Pages: 1013–1017, Yoshiaki Kawano, Wataru Takahashi, Masatoshi Eto, Tomomi Kamba, Hideaki Miyake, Masato Fujisawa, Takao Kamai, Hirotsugu Uemura, Taiji Tsukamoto, Haruhito Azuma, Akio Matsubara, Kazuo Nishimura, Tsuyoshi Nakamura, Osamu Ogawa and Seiji Naito

    Version of Record online : 14 JUN 2016, DOI: 10.1111/cas.12951

  18. You have free access to this content
    Optimal management of metastatic renal cell carcinoma: an algorithm for treatment

    BJU International

    Volume 104, Issue 1, July 2009, Pages: 10–18, Joaquim Bellmunt, Per Flodgren, Jan Roigas and Stéphane Oudard

    Version of Record online : 21 APR 2009, DOI: 10.1111/j.1464-410X.2009.08563.x

  19. Renal Cell Carcinoma

    Standard Article

    Holland-Frei Cancer Medicine

    Earle F. Burgess, Stephen B. Riggs, Brian I. Rini and Derek Raghavan

    Published Online : 26 FEB 2017, DOI: 10.1002/9781119000822.hfcm097

  20. You have free access to this content
    Progression-free survival: Does a correlation with survival justify its role as a surrogate clinical endpoint?

    Cancer

    Volume 120, Issue 1, 1 January 2014, Pages: 7–10, Andreas Becker, Christian Eichelberg and Maxine Sun

    Version of Record online : 8 OCT 2013, DOI: 10.1002/cncr.28378